- Home
- CGEN vs EFSI Comparison
CGEN vs EFSI Comparison
Compare CGEN & EFSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEN
- EFSI
- Stock Information
- Founded
- CGEN 1993
- EFSI 1881
- Country
- CGEN Israel
- EFSI United States
- Employees
- CGEN N/A
- EFSI N/A
- Industry
- CGEN Biotechnology: Biological Products (No Diagnostic Substances)
- EFSI Major Banks
- Sector
- CGEN Health Care
- EFSI Finance
- Exchange
- CGEN Nasdaq
- EFSI Nasdaq
- Market Cap
- CGEN 167.4M
- EFSI 161.4M
- IPO Year
- CGEN 2000
- EFSI N/A
- Fundamental
- Price
- CGEN $1.64
- EFSI $29.26
- Analyst Decision
- CGEN
- EFSI Strong Buy
- Analyst Count
- CGEN 0
- EFSI 2
- Target Price
- CGEN N/A
- EFSI $40.00
- AVG Volume (30 Days)
- CGEN 264.8K
- EFSI 18.4K
- Earning Date
- CGEN 08-05-2025
- EFSI 04-25-2025
- Dividend Yield
- CGEN N/A
- EFSI 4.25%
- EPS Growth
- CGEN N/A
- EFSI N/A
- EPS
- CGEN N/A
- EFSI 1.52
- Revenue
- CGEN $27,589,000.00
- EFSI $58,067,000.00
- Revenue This Year
- CGEN N/A
- EFSI $3.16
- Revenue Next Year
- CGEN $173.80
- EFSI $22.35
- P/E Ratio
- CGEN N/A
- EFSI $19.12
- Revenue Growth
- CGEN N/A
- EFSI N/A
- 52 Week Low
- CGEN $1.13
- EFSI $28.70
- 52 Week High
- CGEN $2.66
- EFSI $36.93
- Technical
- Relative Strength Index (RSI)
- CGEN 54.29
- EFSI N/A
- Support Level
- CGEN $1.65
- EFSI N/A
- Resistance Level
- CGEN $1.83
- EFSI N/A
- Average True Range (ATR)
- CGEN 0.10
- EFSI 0.00
- MACD
- CGEN -0.01
- EFSI 0.00
- Stochastic Oscillator
- CGEN 47.50
- EFSI 0.00
About CGEN Compugen Ltd.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
About EFSI Eagle Financial Services Inc Common Stock
Eagle Financial Services Inc is a locally owned and managed financial institution. It offers retail and commercial banking services, including demand, savings and time deposits and consumer, mortgage, and commercial loans. It also offers telephone banking, internet banking, and mobile banking to its customers. The Company has three reportable operating segments, Community Banking, Marine Lending and Wealth Management. It generates a majority of its revenue from the Community Banking segment.